Literature DB >> 26555863

Effects of aneuploidy on gene expression: implications for cancer.

Milena Dürrbaum1,2, Zuzana Storchová1,2.   

Abstract

Unbalanced chromosome content, so-called aneuploidy, is a hallmark of cancer cells. Changes in the copy numbers of chromosomes or large chromosomal regions significantly alter the expression of several hundreds of genes that are gained or lost. At the same time, aneuploidy per se affects the transcription of many genes throughout the entire genome, as several pathways are activated or inhibited in response to changes in chromosome copy number. In recent years, a large amount of quantitative genome, transcriptome and proteome data has enabled comparison of the changes in gene expression observed in aneuploid cancer cells, as well as in model aneuploid cells with defined karyotypes. Here, we summarize how aneuploidy shapes gene expression and how it may contribute to the phenotypes of cancer cells.
© 2015 FEBS.

Entities:  

Keywords:  Aneuploidy; Cancer; Chromosomal Instability; Transcription; Trisomy

Mesh:

Substances:

Year:  2015        PMID: 26555863     DOI: 10.1111/febs.13591

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  34 in total

1.  Global Analysis of Gene Expression in Response to Whole-Chromosome Aneuploidy in Hexaploid Wheat.

Authors:  Ai Zhang; Ning Li; Lei Gong; Xiaowan Gou; Bin Wang; Xin Deng; Changping Li; Qianli Dong; Huakun Zhang; Bao Liu
Journal:  Plant Physiol       Date:  2017-08-18       Impact factor: 8.340

Review 2.  Determinants and clinical implications of chromosomal instability in cancer.

Authors:  Laurent Sansregret; Bart Vanhaesebroeck; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2018-01-03       Impact factor: 66.675

3.  Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.

Authors:  Run Shi; Jing Sun; Qi Sun; Quanli Zhang; Wenjie Xia; Gaochao Dong; Anpeng Wang; Feng Jiang; Lin Xu
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

4.  The frequency and consequences of multipolar mitoses in undifferentiated embryonic stem cells.

Authors:  Veronika Pospisilova; Milan Esner; Iveta Cervenkova; Radek Fedr; Jean-Yvez Tinevez; Ales Hampl; Martin Anger
Journal:  J Appl Biomed       Date:  2019-11-11       Impact factor: 1.797

5.  KNTC1 as a putative tumor oncogene in pancreatic cancer.

Authors:  Ling Liu; Hongwei Chen; Xinan Chen; Chenjie Yao; Weimin Shen; Changku Jia
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-19       Impact factor: 4.322

6.  Chromosome-wide gene dosage rebalance may benefit tumor progression.

Authors:  Honglei Zhang; Xing Yang; Xu Feng; Haibo Xu; Qin Yang; Li Zou; Mei Yan; Dequan Liu; Xiaosan Su; Baowei Jiao
Journal:  Mol Genet Genomics       Date:  2018-03-15       Impact factor: 3.291

7.  Extreme Downregulation of Chromosome Y and Cancer Risk in Men.

Authors:  Alejandro Cáceres; Aina Jene; Tonu Esko; Luis A Pérez-Jurado; Juan R González
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

8.  Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.

Authors:  Sushant Patkar; Kerstin Heselmeyer-Haddad; Noam Auslander; Eytan Ruppin; Thomas Ried; Daniela Hirsch; Jordi Camps; Daniel Bronder; Markus Brown; Wei-Dong Chen; Rachel Lokanga; Darawalee Wangsa; Danny Wangsa; Yue Hu; Annette Lischka; Rüdiger Braun; Georg Emons; B Michael Ghadimi; Jochen Gaedcke; Marian Grade; Cristina Montagna; Yuri Lazebnik; Michael J Difilippantonio; Jens K Habermann; Gert Auer
Journal:  Genome Med       Date:  2021-05-25       Impact factor: 11.117

Review 9.  Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Authors:  Mengke Niu; Ming Yi; Ning Li; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-03-02

Review 10.  Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice.

Authors:  Chiara Agnoletto; Chiara Caruso; Cecilia Garofalo
Journal:  Cancers (Basel)       Date:  2021-05-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.